Brainfarma Tech Stack

Brazilian pharmaceutical manufacturer scaling oligonucleotide and oncology production

Pharmaceutical Manufacturing Anápolis, Goiás 1,001–5,000 employees Founded 2002 Public Company

Brainfarma is a 1,000–5,000-person pharmaceutical manufacturer in Anápolis, Brazil, operating one of Latin America's largest production facilities. The company is investing heavily in advanced chemistry capabilities—oligonucleotide purification, preparative chromatography optimization, and oncology pipeline projects—while maintaining core generic and similar-drug manufacturing. The tech stack reveals a hybrid operation: traditional pharma (LIMS, HPLC, LC-MS, chromatography software) paired with modern infrastructure (Python, Flask, PostgreSQL, Docker, Azure DevOps, GCP, OpenAI API), suggesting active R&D automation and process digitization.

Tech Stack 31 technologies

Core StackSAP Python Flask PostgreSQL SQL Server Celery Redis Azure DevOps Linux Docker RAG Excel Word LIMS HPLC LC-MS Git OpenAI API PowerPoint Microsoft Office Microsoft 365 Microsoft Access Outlook Teams GCP Chromeleon Microsoft Project Ariba Coupa Agilent+1 more

What Brainfarma Is Building

◆Challenges

Reducing recurring equipment failures
Quality deviations
Chromatographic process scaling
Reducing maintenance costs
Reducing production losses
Cost and deadline optimization
Cost analysis for new projects
Transposição de tecnologia entre plantas
Investigação de desvios de processo
Equipment qualification compliance

▲Active Projects

Projeto de alta complexidade no núcleo de oncológico
Projeto alca
Document inspection
Oligonucleotide purification method development
Product launch projects
Outsourcing production lines
Supplier qualification program
Desenvolvimento de métodos de purificação de oligonucleotídeos
Otimização e escalonamento de processos cromatográficos preparativos
Avaliação toxicológica de ifas

Hiring Activity

Steady100 roles · 35 in 30d

Department

Manufacturing

Research

Ops

Engineering

Logistics

Healthcare

Quality

Data

Seniority

Junior

Mid

Senior

Intern

Lead

Manager

Company intelligence

Find more companies like Brainfarma by tech stack, pain points and active projects

Get started free

About Brainfarma

Brainfarma manufactures pharmaceuticals and chemical products for the Brazilian market, holding registrations for established consumer brands (Doralgina, Gastrol, Histamin, Massageol) under the Neo Química label, alongside generic and similar-drug offerings. The company is majority-owned by Hypera S.A., its primary distributor. Manufacturing footprint is concentrated in Anápolis, Goiás, where a large-scale facility handles formulation, synthesis, and quality testing. Current hiring is manufacturing-focused (31 roles), followed by research (23) and operations (14), with smaller teams in engineering (11) and data (3)—indicating a production-heavy org ramping capacity rather than wholesale transformation.

HeadquartersAnápolis, Goiás

Company Size1,001–5,000 employees

Founded2002

Hiring MarketsBrazil

Frequently Asked Questions

What manufacturing capabilities is Brainfarma developing?

Active projects include oligonucleotide purification methods, preparative chromatography process scaling, and oncology-focused R&D. The company is also qualifying suppliers and outsourcing select production lines, signaling portfolio diversification beyond traditional generics.

What technology does Brainfarma use for drug development?

Lab infrastructure includes LIMS, HPLC, LC-MS, and Chromeleon chromatography software. Backend systems run Python, Flask, PostgreSQL, Docker, and Azure DevOps; the company also uses OpenAI APIs and GCP, indicating process automation and data pipeline work.